Prenatal contributions to epilepsy: Lessons from the bedside

Epileptic Disorders

Volumn 5, Issue 2, 2003, Pages 77-91

  Scher, Mark S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Epilepsy; Fetus; Maternal diseases; Neonate; Placenta; Prenatal

Indexed keywords

GENE PRODUCT;

ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN MALFORMATION; BRAIN NECROSIS; DEVELOPMENTAL DISORDER; DISEASE DURATION; EMBRYO DEVELOPMENT; EPILEPSY; FERTILIZATION; FETUS DISEASE; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GRAY MATTER; HUMAN; LEARNING; MATERNAL DISEASE; MEDICAL RESEARCH; MEDICAL SPECIALIST; MOTOR CORTEX; NEUROLOGY; NEWBORN DISEASE; PERINATAL PERIOD; PLACENTA DISORDER; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SEIZURE; VASCULAR DISEASE; WHITE MATTER;

BRAIN; BRAIN DAMAGE, CHRONIC; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SPASMS, INFANTILE;

EID: 0038383961     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (119)

1. Spreafico R, Avanzini G, Andermann F, (Eds). Abnormal cortical development and epilepsy: In: Basics in Clinical Science. Mariani Foundation Pediatric Neurology Series: 7, London: John Libbey, 1999; pgs 1-324.
2. Nehlig A, Motte J, Moshé SL, Plouin P (Eds). Childhood epilepsies and brain development. London: John Libbey and Co., 1999: 1-311.
3. Dobyns WB. The genetic basis of malformations of neuronal migration: Molecular mechanisms and clinical correlation. Chapt 22 In: Abnormal cortical development in epilepsy. R Spreafico, et al., City ? ? ?: Publisher ? ? ?, 1999: 261-71.
4. Barkovich AJ, Kuzniecky RI, Jackson GD, et al. Classification system for malformations of cortical development Update 2001. Neurology 2001; 57: 2168-78.
5. Hughes PE, Alexi T, Walton M, et al. Activity and injury dependent expression of inducible transcription factors, growth factors, and apoptosis-related genes within the central nervous system. Prog Neuro Biol 1999; 57: 421-50.
6. Bredesen DE. Neural apoptosis. Ann Neurol 1995; 38: 839-51.
7. Brain Plasticity and Epilepsy. Papers presented at the Fifth Workshop on the neurobiology of epilepsy (WONOEP V). Moshé, SL (Guest Ed.) Lippincott Williams & Wilkins Epilepsia 2000; 41; S1-S206.
8. Holmes GL, Ben-Ari Y. The neurobiology and consequences of epilepsy in the developing brain. Pediatr Res 2001a; 49: 320-5.
9. Holmes GL, McCabe B. Brain development in generation of brain pathologies. Intl Rev Neurobiol 2001b; 45: 17-41.
10. Collins DL, Holmes CJ, Peters TM, et al. Automatic 3D model-based neuroanatomical segmentation. Hum Brain Mapp 1995; 3: 1990-208.
11. Giedd J, Blumenthal J, Jeffries N, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2001; 2: 861-3.
12. Miller G, Clark GD. The Cerebral Palsies: Causes, Consequences, and Management. Boston: Butterworth-Heinemann, 1998: 1-368.
13. Luckasson R, Coulter DL, Polloway DA, et al. Mental retardation: definition, classification, and systems of supports. Ninth edition. Washington DC: American Association of Mental Retardation, 1992.
14. Yeargin-Allsopp M, Murphy CC, Cordero JF, et al. Reported by medical causes and associated medical conditions for mental retardation among ten-year-old children, metropolitan Atlanta, 1985-1987. Dev Med Child Neurol 1997; 39: 142-9.
15. Cantwell DP. Attention deficit disorder: a review over the past ten years. J Am Acad Child Adolesc Psych 1996; 35: 978-87.
16. Scher MS. Fetal and neonatal neurologic consultations: identifying brain disorders in the context of fetal-maternal-placental disease. Semin Ped Neurol 2001; 8: 55-73.
17. Leventer RJ, Phelan EM, Coleman LT, et al. Clinical and imaging features of cortical malformations in childhood. Neurology 1999; 53: 715-22.
18. Palmini A, Andermann E, Andermann F. Prenatal events and genetic factors in epileptic patients with neuronal migration disorders. Epilepsia 1994; 35: 965-73.
19. Sidenvall R, Heijbel J, Blomquist HK, et al. An incident case-control study of first unprovoked afebrile seizures in children: a population-based study of pre- and perinatal risk factors. Epilepsia 2001; 42: 1261-5.
20. Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J, et al. Unilateral polymicrogyria: a common cause of hemiplegia of prenatal origin. Brain Dev 2001; 23: 216-22.
21. Marín-Padilla M. Chapter 3. Acquired neonatal encephalopathies: cortical vasculature, postinjury reorganization, and neurological sequelae. In: Spreafico R, Avanzini G, Andermann F (Eds). Abnormal Cortical Development and Epilepsy. London: John Libbey and Co, 1999: 35-54.
22. Barth PG, van der Harten JJ. Parabiotic twin syndrome with topical isocortical disruption and gastroschisis. Acta Neuropathol 1985; 67: 345-9.
23. Bordarier C, Robain O. Microgyren necrotic cortical lesions in twin fetuses: original cerebral damage consecutive to twinning ? Brain Dev 1992; 14: 174-8.
24. West MJ, King AP. Settling nature and nurture into ontogenetic niche. Dev Psychol 1987; 20: 549-62.
25. Swartz B. Experience, brain, and behavior: the importance of a head start. Pediatrics 1999; 103: 1031-5.
26. Gressens P. Mechanisms of cerebral dysgenesis. Curr Opin Pediatr 1998; 10: 556-60.
27. Gressens P. Mechanisms and disturbances of neuronal migration. Pediatr Res 2000; 48: 725-30.
28. Dammerman RS, Kriegstein AR. Transient actions of neurotransmitters during neocortical development. Epilepsia 2000; 41: 1080-1.
29. Frantz GD, Weimann JM, Levin ME, McConnel SK, Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J Neurosci 1994; 114: 5725-40.
30. Avanzini G, Spreafico R, Cipelletti B, et al. Synaptic properties of neocortical neurons in epileptic mice lacking the Otx1 gene. Epilepsia 2000; 41 (Suppl 6): S200-5.
31. Knudson Jr AG. Genetics of human cancer. Ann Rev Genet 1986; 20: 231-51.
32. Sepp T, Yates JRW, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996; 33: 962-4.
33. Briellmann RS, Jackson GD, Torn-Broers Y, et al. Causes of epilepsies: insights from discordant monozygous twins. Ann Neurol 2001; 49: 45-52.
34. Montenegro MA, Guerreiro MM, Lopes-Cendes I, et al. Interrelationship of genetics and prenatal injury in the genesis of malformations of cortical development. Arch Neurol 2002; 59: 1147-53.
35. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278: 207-11.
36. Nelson KB, Dambrosia JM, Grether JK, et al. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-75
37. Nelson KB, Willoughby RE. Overview: infection during pregnancy and neurologic outcome in the child. MRDD Res Rev 2002; 8: 1-2.
38. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-1 beta and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177: 19-26.
39. Dammann O, Hagberg H, Leviton A. Is periventricular leukomalacia an axonopathy as well as an oligopathy? Pediatr Res 2001; 49: 453-7.
40. Whiting S, Duchowny M. Clinical spectrum of cortical dysplasia in childhood: diagnosis and treatment issues. J Child Neurol 1999; 14: 759-71.
41. Tassi L, Colombo N, Garbelli R, Francione S, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002; 125: 1719-32.
42. Lee SK, Choe G, Hong KS, Nam HW. Neuroimaging findings of cortical dyslamination with cytomegaly. Epilepsia 2001; 42: 850-6.
43. Eriksson SH, Symms MR, Rugg-Gunn FJ, Boulby PA. Exploring white matter tracts in band heterotopia using diffusion tractography. Ann Neurol 2002; 52: 327-34.
44. Duchowny M, Jayakar P, Levin B. Aberrant neural circuits in malformations of cortical development and focal epilepsy. Neurology 2000; 55: 423-8.
45. Klein B, Levin BE, Duchowny MS, Llabre MM. Cognitive outcome of children with epilepsy and malformations of cortical development. Neurology 2000; 55: 230-5.
46. Lawn N, Londono A, Sawrie S, Morawetz R, et al. Occipitoparietal epilepsy, hippocampal atrophy and congenital developmental abnormalities. Epilepsia 2000; 41: 1546-53.
47. Amess PN, Baudin J, Townsend J, Meek J, et al. Epilepsy in very preterm infants: neonatal cranial ultrasound reveals a high-risk subcategory. Dev Med Child Neurol 1998; 40: 724-30.
48. Hermann B, Seidenberg M, Bell B, Rutecki P. The neurodevelopmental impact of childhood-onset temporal lobe epilepsy on brain structure and function. Epilepsia 2002; 43: 1062-71.
49. Inder TE, Huppi PS, Zientara GP, et al. The postmigrational development of polymicrogyria documented by magnetic resonance imaging from 31 weeks' postconceptional age. Ann Neurol 1999; 45: 798-801.
50. Gurses C, Gross DW, Andermann F, et al. Periventricular leukomalacia and epilepsy. Neurology 1999; 52: 341-5.
51. Lynch JK, Nelson KB. Epidemiology of perinatal stroke. Curr Opin Pediatr 2001; 13: 499-505.
52. Scher MS, Wiznitzer M, Bangert BA. Cerebral infarctions in the fetus and neonate: maternal-placental-fetal considerations. Clin Perinatol 2002a; 29: 1-32.
53. Golomb MR, MacGregor DL, Domi T, et al. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol 2001; 50: 163-8.
54. 2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsy 2002; 43: 52-9.
55. Delorne MA, Burrows RF, Ofosu FA, et al. Thrombin regulation in mother and fetus during pregnancy. Semin Thromb Hemost 1992; 18: 81-90.
56. Silver RK, MacGregor SN, Pasternak JF, et al. Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet Gynecol 1992; 80: 497-9.
57. Ballem P. Acquied thrombophilia in pregnancy. Semin Thromb Hemost 1998; 24 (Suppl 1): 41-7.
58. Rigo Jr J, Nagy B, Fintor L, et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5.10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000; 19: 163-72.
59. Duley L, Henderson-Smart D, Knight M, et al. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systemic review. Br Med J 2001; 322: 329-33.
60. Easterling TR, Carr DB, Davis C, et al. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol 2000; 96: 956-61.
61. Impey L, Greenwood C, Sheil O, et al. The relation between pre-eclampsia at term and neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2001; 83: F170-2.
62. Uvebrant P. Hemiplegic cerebral palsy aetiology and outcome. Acta Paediatr 1988; 345 (Suppl): 1-100.
63. Arias F, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998; 7: 277-86.
64. de Vries JIP, Dekker GA, Huigens PC, et al. Hyperhomocysteinaemia and protein S. deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997; 104: 1248-54.
65. Dizon-Townson DS, Meline L, Nelson LM, et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997; 177: 402-5.
66. rd edition. New York: Springer-Verlag; 1995: 360-5.
67. Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis. Med Clin North Am 1998; 82: 409-58
68. Zoller B, Dahlbeck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1999; 343: 1536-8.
69. Thorarensen O, Ryan S, Hunter J, et al. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol 1997; 42: 372-5.
70. Marengo-Rowe AJ, Leveson JE. The antiphospholipid antibody syndrome. Baylor University Medical Center Proceedings 1996; 9: 21-4.
71. Tanne D, D'Olhaberriague L, Schultz LR, et al. Anticardiolipin antibodies and their associations with cerebrovascular risk factors. Neurology 1999; 52: 1368-73.
72. Becker S, Heller C, Gropp F, et al. Thrombophilic disorders in children with cerebral infarction. Lancet 1998; 352: 1756-7.
73. Barron TF, Gusnard DA, Zimmerman RA, et al. Cerebral venous thrombosis in neonates and children. Pediatr Neurol 1992; 8: 112-6.
74. Brenner B, Fishman A, Goldsher D, et al. Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 1988; 27: 209-11.
75. Kuban KCK, Leviton A. Cerebral palsy. N Engl J Med 1994; 330: 188-95.
76. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335: 108-14.
77. Manco-Johnson MJ, Abshire TC, Jacobson LJ, et al. Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr 1991; 119: 793-7.
78. Smith RA, Skelton M, Howard M, et al. Is thrombophilia a factor in the development of hemiplegic cerebral palsy. Dev Med Child Neurol 2001; 43: 724-30.
79. Gruenwald P. Abnormalities of placental vascularity in relation to intrauterine deprivation and retardation of fetal growth: significance of avascular chorionic villi. NY State J Med 1961; 61: 1508-13.
80. Fox H. Thrombosis of the foetal stem arteries in the human placenta. J Obstet Gynaecol Br Commonw 1966; 73: 961-5.
81. Gross RE. Arterial embolism and thrombosis in infancy. Am J Dis Child 1945; 70: 61-73.
82. Da Sa DJ. Intimal cushions of foetal placental veins. J Pathol 1973; 110: 347-52.
83. Scott JM. Fibrinous vasculosis in the human placenta. Placenta 1983; 4: 87-100.
84. Sander CH. Hemorrhagic endovasculitis and hemorrhagic villitis of the placenta. Arch Pathol Lab Med 1980; 104: 371-3.
85. Sander CH, Kinnane L, Stevens NG, et al. Haemorrhagic endovasculitis of the placenta: a review with clinical correlation. Placenta 1986; 7: 551-74.
86. Rayne SC, Kraus FT. Placental thrombi and other vascular lesions: classification, morphology, and clinical correlations. Pathol Res Pract 1993; 189: 2-17.
87. Kraus FT. Placental thrombi and related problems. Semin Diagn Pathol 1993; 10: 275-83.
88. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995; 26: 80-5.
89. Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol 1999; 30: 759-69.
90. Kraus FT. Cerebral palsy and thrombi in placental vessels of the fetus: insights from litigation. Hum Pathol 1997; 28: 246-8.
91. Hagberg H, Mallard C. Antenatal brain injury: etiology or possibilities of prevention. Semin Neonatol 2000; 5: 41-51.
92. Felix JF, Badawi N, Kurinczuk JJ, et al. Birth defects in children with newborn encephalopathy. Dev Med Child Neurol 2000; 42: 803-8.
93. Bergamasco B, Benna P, Ferrero P, Gavinelli R. Neonatal hypoxia and epileptic risk: a clinical prospective study. Epilepsia 1984; 25: 131-6.
94. Ishikawa T, Kishi S, Inukai K, Kono C, et al. Subsequent epilepsy in very-low-birthweight infants: a long-term follow-up study from birth. Epilepsia 1995; 36: 435-9.
95. Todorova MT, Burwell TJ, Seyfried TN. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999; 40: 1697-707.
96. Sue CM, Hirano M, DiMauro S, et al. Neonatal presentations of mitochondrial meta//bolic disorders. Semin Perinatol 1999; 23: 113-24.
97. Nissenkorn A, Michelson M, Ben-Zeev B, Lerman-Sagie T. Inborn errors of metabolism A cause of abnormal brain development. Neurology 2001; 56: 1265-72.
98. Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia 1991; 32: 69-76.
99. Scher MS, Aso K, Beggarly ME, et al. Electrographic seizures in preterm and fullterm neonates: clinical correlates, associated brain lesions, and risk for neurological sequelae. Pediatrics 1993a; 91: 128-34.
100. Bye MA, Cunningham CA, Shee KY, et al. Outcome of neonates with electrographically identified seizures, are at risk for seizures. Pediatr Neurol 1997; 16: 225-31.
101. Scher MS. Controversies regarding neonatal seizure recognition. Epileptic Disord 2002; 4: 138-58.
102. Blackwell SC, Refuerzo JS, Wolf HM, et al. The relationship between nucleated red blood cell counts at early onset neonatal seizures. Am J Obstet Gynecol 2000; 182: 1452-7.
103. Scher MS, Trucco J, Beggarly ME, et al. Neonates with electrically confirmed seizures and possible placental associations. Pediatr Neurol 1998; 19: 37-41.
104. Scher MS, Hamid MY, Steppe DA, et al. Ictal and interictal durations in preterm and term neonates. Epilepsia 1993b; 34: 284-8.
105. Scher MS, Alvin J, Painter MJ. Uncoupling of clinical and EEG seizures after antiepileptic drug use in neonates. Pediatr Neurol, in press.
106. Sanchez RM, Jensen FE. Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia 2001; 42: 577-85.
107. Raymond AA, Fish DR, Stevens JM, Cook MJ. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology 1994; 44: 1841-5.
108. Sato N, Hatakeyama S, Shimizu N, Hikima A. MR evaluation of the hippocampus in patients with congenital malformations of the brain. AJNR 2001; 22: 389-93.
109. Mohamed A, Wyllie E, Ruggieri P, et al. Temporal lobe epilepsy due to hippocampal sclerosis in pediatric candidates for epilepsy surgery. Neurology 2001; 56: 1643-9.
110. Ho SS, Kuzniecky RI, Gilliam F, Faught E, et al. Congenital porencephaly and hippocampal sclerosis. Neurology 1997; 49: 1382-8.
111. Scott RC, Gadian DG, Cross JH, et al. Quantitative magnetic resonance characterization of mesial temporal sclerosis in children. Neurology 2001; 56: 1659-65.
112. Schwartzkroin PA. Origins of the epileptic state. Epilepsia 1997; 38: 853-8.
113. Jacobs MP, Fischbach GD, Davis MR, et al. Future directions for epilepsia research. Neurology 2001; 57: 1536-42.
114. Chevassus-au-Louis N, Baraban SC, Gaïarsa J-L, Ben-Ari Y. Cortical malformations and epilepsy: new insights from animal models. Epilepsia 1999; 40: 811-21.
115. Liu Y, Silverstein FS, Skoff R, Barks JDE. Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 2002; 51: 25-33.
116. Rees S, Stringer M, Just Y, et al. The vulnerability of the fetal sheep brain to hypoxemia at mid-gestation. Brain Res Dev Brain Res 1997; 103: 103-18.
117. Kusaka T, Matsuda T, Okuyama K, Cho K, et al. Analyses of factors contributing to vulnerability to antenatal periventricular leukomalacia induced by hemorrhagic hypotension in chronically instrumented fetal sheep. Pediatr Res 2002; 51: 20-4.
118. Evrard P. Pathophysiology of perinatal brain damage. Dev Neurosci 2001; 23: 171-4.
119. First World Congress. Fetal origins of adult disease. Pediatr Res 2001; 50 (suppl): 1-68A.